Tocotrienols and metabolic

What 2 graded rows on tocotrienols agree on for metabolic, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Tocotrienols page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Tocotrienols page, with its PubMed record.

Supplement

Tocotrienols Choose another

2 rows · 148 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade D, is a randomized trial of 77 people (2022) and found an improvement.

The rows run from 71 to 77 people, published from 2020 to 2022: 2 single studies.

2 improved

Grade DGlucose control in prediabetes · Improved
RCT · n 77 · 2022 · Adults aged 18–60 with prediabetes in Pakistan
300 mg/day · 12 weeks
Fasting glucose, HbA1c, insulin and HOMA-IR fell more than with placebo.
Row on the Tocotrienols page · PubMed 35099428 (opens PubMed)
Grade DFatty-liver index and insulin resistance · Improved
RCT · n 71 · 2020 · Adults with nonalcoholic fatty liver disease
600 mg/day (300 mg twice daily) · 24 weeks
Fatty-liver index, HOMA-IR, CRP, ALT and AST fell more than with placebo, and ultrasound steatosis improved.
Row on the Tocotrienols page · PubMed 32951743 (opens PubMed)